Pre-clinical to Clinical Translational Failures and Current Status of Clinical Trials in Stroke Therapy: A Brief Review

In stroke (cerebral ischemia), despite continuous efforts both at the experimental and clinical level, the only approved pharmacological treatment has been restricted to tissue plasminogen activator (tPA). Stroke is the leading cause of functional disability and mortality throughout worldwide. Its p...

Descripción completa

Detalles Bibliográficos
Autores principales: Dhir, Neha, Medhi, Bikash, Prakash, Ajay, Goyal, Manoj Kumar, Modi, Manish, Mohindra, Sandeep
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7457423/
https://www.ncbi.nlm.nih.gov/pubmed/31934841
http://dx.doi.org/10.2174/1570159X18666200114160844

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7457423/
https://www.ncbi.nlm.nih.gov/pubmed/31934841
http://dx.doi.org/10.2174/1570159X18666200114160844

Ejemplares similares